Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Adamas Pharma (NQ: ADMS )

4.750 USD +0.020 (+0.42%)
Official Closing Price Updated: 7:26 PM EST, Feb 25, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 4,911,600
Open 4.630
Bid (Size) 4.650 (12)
Ask (Size) 4.800 (5)
Prev. Close 4.730
Today's Range 4.630 - 5.440
52wk Range 1.900 - 9.150
Shares Outstanding 26,982,322
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Adamas Pharmaceuticals Announces Pricing of Follow-on Public Offering
Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS), a company dedicated to developing and delivering medicines that make a meaningful difference to people affected by neurological diseases, today announced... 
From Business Wire News Releases
Adamas Pharmaceuticals Announces Launch of Follow-on Public Offering
Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS), a company dedicated to developing and delivering medicines that make a meaningful difference to people affected by neurological diseases, today announced... 
From Business Wire News Releases

Performance

YTD
+6.03%
+6.03%
1 Month
-15.48%
-15.48%
3 Month
+6.74%
+6.74%
6 Month
-5.94%
-5.94%
1 Year
+7.22%
+7.22%

More News

Read More
Adamas Reports Fourth Quarter and Full Year 2020 Financial Results
From Business Wire News Releases
Adamas to Present at Upcoming Healthcare Conferences
From Business Wire News Releases
Adamas to Announce Fourth Quarter and Year-End 2020 Financial Results and Host Conference Call on February 23, 2021
From Business Wire News Releases
First Week of April 16th Options Trading For Adamas Pharmaceuticals (ADMS)
Tags Stocks
From Market News Video
Adamas Pharmaceuticals: Q4 Earnings Insights
Tags BZI/Recaps ADMS Benzinga
From Benzinga
A Preview Of Adamas Pharmaceuticals's Earnings
Tags Earnings Benzinga Market News
From Benzinga
Adamas Announces FDA Approval for Second Indication for GOCOVRI® as an Adjunctive Treatment to levodopa/carbidopa in Parkinson’s Disease Patients Experiencing OFF Episodes
From Business Wire News Releases
12 Health Care Stocks Moving In Tuesday's Intraday Session
Tags ADMS Markets Market News
From Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Tags Market News ADMS EYPT
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.